Athira Pharmacy, formerly M3 Biotechnology, is a pharmaceutical company with a primary focus on Alzheimer’s Disease progression and neuro-deterioration. Current therapies primarily address the symptoms; M3 is developing disease-modifying treatments with the potential to restore lost connections between brain cells.